Aberrant expression of protein tyrosine phosphatases (PTPs) has been implicated in various cancers, exerting either tumour-suppressive functions through dephosphorylation of oncogenic proteins or promoting cancer development and progression by positively regulating other signalling pathways3,19,20. The gene discussed is PTS; the disease is cancer.